Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers

Journal of Urology

Volumn 183, Issue 5, 2010, Pages 1744-1750

  Shariat, Shahrokh F ^a   Youssef, Ramy F ^a   Gupta, Amit ^a   Chade, Daher C ^a   Karakiewicz, Pierre I ^b   Isbarn, Hendrik ^b   Jeldres, Claudio ^b   Sagalowsky, Arthur I ^a   Ashfaq, Raheela ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

immunohistochemistry; recurrence; survival; urinary bladder neoplasms; vascular endothelial growth factors

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; CYCLIN D1; CYCLIN E; CYCLOOXYGENASE 2; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; SURVIVIN; THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CELL CYCLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AREA UNDER CURVE; CYSTECTOMY; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950518406     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.01.018     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225
2. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414
3. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
4. Bellmunt J., and Hautmann R.E. Open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival. Eur Urol 54 (2008) 1192
5. Donat S.M. Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. J Natl Compr Canc Netw 7 (2009) 40
6. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1 (1995) 27
7. Bernardini S., Fauconnet S., Chabannes E., et al. Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. J Urol 166 (2001) 1275
8. Bochner B.H., Cote R.J., Weidner N., et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87 (1995) 1603
9. Gazzaniga P., Gandini O., Gradilone A., et al. Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses. Int J Oncol 14 (1999) 1123
10. Grossfeld G.D., Ginsberg D.A., Stein J.P., et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89 (1997) 219
11. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361
12. Weinstat-Saslow D.L., Zabrenetzky V.S., VanHoutte K., et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54 (1994) 6504
13. Zabrenetzky V., Harris C.C., Steeg P.S., et al. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59 (1994) 191
14. el-Deiry W.S., Tokino T., Velculescu V.E., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817
15. Michieli P., Chedid M., Lin D., et al. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54 (1994) 3391
16. Shariat S.F., Ashfaq R., Sagalowsky A.I., et al. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 37 (2006) 1568
17. Shariat S.F., Zlotta A.R., Ashfaq R., et al. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 20 (2007) 445
18. Wolff E.M., Liang G., and Jones P.A. Mechanisms of disease: genetic and epigenetic alterations that drive bladder cancer. Nat Clin Pract Urol 2 (2005) 502
19. Billottet C., Janji B., Thiery J.P., et al. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene 21 (2002) 8128
20. Miyake H., Hara I., Gohji K., et al. Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. Cancer Lett 123 (1998) 121
21. O'Brien T., Cranston D., Fuggle S., et al. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res 57 (1997) 136
22. Elfiky A.A., and Rosenberg J.E. Targeting angiogenesis in bladder cancer. Curr Oncol Rep 11 (2009) 244
23. Xia G., Kumar S.R., Hawes D., et al. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol 175 (2006) 1245
24. Jaeger T.M., Weidner N., Chew K., et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 154 (1995) 69
25. Slaton J.W., Millikan R., Inoue K., et al. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J Urol 171 (2004) 570
26. Streeter E.H., and Harris A.L. Angiogenesis in bladder cancer-prognostic marker and target for future therapy. Surg Oncol 11 (2002) 85
27. Wang J.M., Kumar S., Pye D., et al. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J Natl Cancer Inst 86 (1994) 386
28. Youssef R.F., Mitra A.P., Bartsch Jr. G., et al. Molecular targets and targeted therapies in bladder cancer management. World J Urol 27 (2009) 9